Literatura académica sobre el tema "Proteina TDP43"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Proteina TDP43".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Proteina TDP43"
Hill, Sarah J., Daniel A. Mordes, Lisa A. Cameron, Donna S. Neuberg, Serena Landini, Kevin Eggan y David M. Livingston. "Two familial ALS proteins function in prevention/repair of transcription-associated DNA damage". Proceedings of the National Academy of Sciences 113, n.º 48 (14 de noviembre de 2016): E7701—E7709. http://dx.doi.org/10.1073/pnas.1611673113.
Texto completoLuo, Jiayi y Paul M. Harrison. "Evolution of sequence traits of prion-like proteins linked to amyotrophic lateral sclerosis (ALS)". PeerJ 10 (17 de noviembre de 2022): e14417. http://dx.doi.org/10.7717/peerj.14417.
Texto completoLaudanski, Krzysztof, Jihane Hajj, Mariana Restrepo, Kumal Siddiq, Tony Okeke y Daniel J. Rader. "Dynamic Changes in Central and Peripheral Neuro-Injury vs. Neuroprotective Serum Markers in COVID-19 Are Modulated by Different Types of Anti-Viral Treatments but Do Not Affect the Incidence of Late and Early Strokes". Biomedicines 9, n.º 12 (29 de noviembre de 2021): 1791. http://dx.doi.org/10.3390/biomedicines9121791.
Texto completoCarter, G. Campbell, Chia-Heng Hsiung, Leman Simpson, Haopeng Yang y Xin Zhang. "N-terminal Domain of TDP43 Enhances Liquid-Liquid Phase Separation of Globular Proteins". Journal of Molecular Biology 433, n.º 10 (mayo de 2021): 166948. http://dx.doi.org/10.1016/j.jmb.2021.166948.
Texto completoRaghunathan, Rekha, Kathleen Turajane y Li Chin Wong. "Biomarkers in Neurodegenerative Diseases: Proteomics Spotlight on ALS and Parkinson’s Disease". International Journal of Molecular Sciences 23, n.º 16 (18 de agosto de 2022): 9299. http://dx.doi.org/10.3390/ijms23169299.
Texto completoTanaka, Hikari y Hitoshi Okazawa. "PQBP1: The Key to Intellectual Disability, Neurodegenerative Diseases, and Innate Immunity". International Journal of Molecular Sciences 23, n.º 11 (2 de junio de 2022): 6227. http://dx.doi.org/10.3390/ijms23116227.
Texto completoLee, Yichen, Bo H. Lee, William Yip, Pingchen Chou y Bak-Sau Yip. "Neurofilament Proteins as Prognostic Biomarkers in Neurological Disorders". Current Pharmaceutical Design 25, n.º 43 (9 de enero de 2020): 4560–69. http://dx.doi.org/10.2174/1381612825666191210154535.
Texto completoJiang, Tianlin, Jiahua Wang, Chao Li, Guiyun Cao y Xiaohong Wang. "Prohibitins: A Key Link between Mitochondria and Nervous System Diseases". Oxidative Medicine and Cellular Longevity 2022 (8 de julio de 2022): 1–13. http://dx.doi.org/10.1155/2022/7494863.
Texto completoTang, Fu-Lei, Lu Zhao, Yang Zhao, Dong Sun, Xiao-Juan Zhu, Lin Mei y Wen-Cheng Xiong. "Coupling of terminal differentiation deficit with neurodegenerative pathology in Vps35-deficient pyramidal neurons". Cell Death & Differentiation 27, n.º 7 (6 de enero de 2020): 2099–116. http://dx.doi.org/10.1038/s41418-019-0487-2.
Texto completoMiguelez-Rodriguez, Aitzol, Jorge Santos-Juanes, Ikerne Vicente-Etxenausia, Katty Perez de Heredia-Goñi, Beatriz Garcia, Luis M. Quiros, Laura Lorente-Gea, Isabel Guerra-Merino, Jose J. Aguirre y Ivan Fernandez-Vega. "Brains with sporadic Creutzfeldt-Jakob disease and copathology showed a prolonged end-stage of disease". Journal of Clinical Pathology 71, n.º 5 (2 de noviembre de 2017): 446–50. http://dx.doi.org/10.1136/jclinpath-2017-204794.
Texto completoTesis sobre el tema "Proteina TDP43"
Fourier, Anthony. "Vers un marqueur biochimique des dégénérescences lobaires fronto-temporales : variations quantitatives et profils protéiques de la protéine TDP43 dans différentes matrices biologiques". Thesis, Lyon, 2018. http://www.theses.fr/2018LYSE1269/document.
Texto completoFrontotemporal lobar degeneration (FTLD) syndrome is the second most common of presenile dementia. FTLD is a clinically heterogeneous syndrome and comprises many hereditary cases. Common neuropathological features rely on a degeneration of the frontal and/or anterior temporal lobes, associated to specific inclusions of aggregated proteins including TAR DNA binding protein 43 (TDP43). Unfortunately, no practical protein marker is currently validated to improve FTLD diagnosis in living patients.A cohort of FTLD patients with definite TDP43 pathology was defined with the development of specific genetic testing. An analysis of TDP43 concentrations in cerebrospinal fluid (CSF) was performed in this cohort and then compared to other cohorts well-characterized on clinical and neuropathological features. Finally, qualitative patterns of TDP43 were studied in compartments accessible from the patient’s living: profiles of soluble TDP43 protein (in CSF or in plasma) and intracellular TDP43 protein (in the formed elements of blood) were compared to protein patterns observed in brain tissues with TDP43 protein inclusions. Platelet samples exhibit similar characteristics to brain tissue and could become a candidate biomarker for FTLD probabilistic diagnosis
Capítulos de libros sobre el tema "Proteina TDP43"
"TARDP (TDP43, Transcription of RNA activating protein/TAR DNA binding protein, human chromosome 1p36.2)". En Encyclopedia of Genetics, Genomics, Proteomics and Informatics, 1930. Dordrecht: Springer Netherlands, 2008. http://dx.doi.org/10.1007/978-1-4020-6754-9_16677.
Texto completoActas de conferencias sobre el tema "Proteina TDP43"
Kim, Patrick Y., Owen Tan, Toby Trahair, Tao Liu, Glenn M. Marshall y Belamy B. Cheung. "Abstract 1403: TRIM16 inhibits cell growth through direct interaction and modulation of TDP43 protein stability in cancer cells". En Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-1403.
Texto completo